Key result
Akkermansia muciniphila alleviates doxorubicin cardiotoxicity and improves mitochondrial function via PPARα/PGC1α.
Why the study?
Doxorubicin-induced cardiotoxicity limits the clinical use of doxorubicin, and the effects of Akkermansia muciniphila on this cardiotoxicity are uncertain.
Does Akkermansia muciniphila supplementation ameliorate doxorubicin-induced cardiotoxicity in preclinical models?
Does Akkermansia muciniphila supplementation ameliorate doxorubicin-induced cardiotoxicity in preclinical models?
Akkermansia muciniphila supplementation shows potential as a probiotic therapy to mitigate doxorubicin-induced cardiotoxicity by improving mitochondrial function via the IPA-AhR-PPARα/PGC1α pathway.
Hypothesis-generating for A. muciniphila in doxorubicin cardiotoxicity; human trials needed before clinical consideration.
Doxorubicin (DOX) is a key chemotherapeutic agent but is also a leading cause of DOX-induced cardiotoxicity (DIC), limiting its clinical use. Akkermansia muciniphila (A. muciniphila), known for its benefits as a probiotic in treating metabolic syndrome, has uncertain effects in the context of DIC. Here, 16S rRNA sequencing of fecal samples from anthracycline-treated patients and DIC mice revealed marked depletion of A. muciniphila. Cardiac transcriptomics, supported by in vitro experiments, showed that A. muciniphila colonization improved mitochondrial function and alleviated DIC by activating the PPARα/PGC1α signaling pathway in both normal and antibiotic-treated C57BL/6 mice. Further analysis uncovered a restructured microbiome-metabolome network following A. muciniphila administration, which contributed to DIC protection. Notably, A. muciniphila supplementation increased serum levels of the tryptophan metabolite indole-3-propionic acid (IPA), which binds to the cardiac aryl hydrocarbon receptor (AhR), leading to the activation of the PPARα/PGC1α signaling pathway. In conclusion, our study sheds light on the potential of A. muciniphila as a probiotic in mitigating DIC.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied Doxorubicin-induced cardiotoxicity. Akkermansia muciniphila was evaluated on Doxorubicin-induced cardiotoxicity and mitochondrial function. Akkermansia muciniphila supplementation alleviated doxorubicin-induced cardiotoxicity and improved mitochondrial function by activating the PPARα/PGC1α signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: